Commercialisation and Industry Involvement
Stephen Locarnini is a named inventor/co-inventor on 14 patents
(9 of which are listed below) and 2 copyright applications (not
listed).
The patents are:
1. PCT/AU2006/000450“Variants of Hepatitis B virus with
resistance to anti-viral nucleoside agents and applications thereof”
Australian Patent Application No:2006230802; Australian Provisional
Patent Application No: 2005903972 to be cognated with Australian
Provisional Patent Application No: 2005901757.
2. PCT/AU2006/001563 “Antiviral resistance mutants and
applications thereof” Australian provisional Patent Application
2005905862.
3. PCT Patent Application PCT/AU2004/001440 “HBV Variants
Detection and Application” Australian Priority No: 2003905776;
Australian Priority No:2004900962; Australian Application No:2004285983;
Europe 04789595.8; South Korea 10-2006-7009823; Japan2006-535911;
China 200480036842.7; Canada 2543538; USA 10/576,906; Hong Kong
07101729.9.
4. Patent Application PCT/AU2005/001538 “Viral mutants
detection and applications” Australian Patent Application
2004905927.
5. PCT/AU2003/00111 Title: “Viral variants with altered
susceptibility to nucleoside analogues and uses thereof”
AUS 2003202301 ; Canada 2475446 ; China 03805162.1 ; Europe 03700697.0
; HK 05103919.7 ; Japan 2003-566192 ; Singapore 200404565-4 (105874)
; USA 10/911,464 ; Hong Kong 05103919.7.
6. PCT/AU2003/00432: Title “Viral variants, detection and
use” Australia 2003213874; Europe 03709442.2; Hong Kong
05104287.9; USA 11/166,004 (10/963,333 abandoned).
7. PCT/AU2005/000716 “Theraputic, prophylactic and diagnostics
agents for Hepatitis B” Australian Patent Application 2005243607;
USA 11/597,063; Europe 05742151.3; China 200580022851.5; Japan
Singapore 200607967.7; Canada 2567301; South Korea 10-2006-7026498;
NZ 551829.
8. Patent Application PCT/AU2004/000781: “Viral polymerase
and modulation thereof” Europe 04736626.5; Australian Provisional
Patent Application No: 2003902983A; US 2004247277; Israel 172430;
India 224/DELNP/2006; Canada 2529309; Mexico PA/a/2005/013566;
USA 11/301,314; China 200480021455.6.
9. Patent Application PCT/AU2004/000349 “Theraputic, prophylactic
and diagnostics agents” Canada 2519864; USA 10/550,198;
AUS 2003901325; Europe 04721774.0.
